Ethical Considerations in Expanded Access for Gene Therapy Companies
Time: 12:15 pm
day: Day Two
Details:
• Recognizing the ethical imperative for gene therapy companies to proactively develop expanded access policies
• Understanding obstacles developers face in providing expanded access to gene therapy products
• Recognizing that conditions with limited windows for treatment deserve special consideration in expanded access
